Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-22T02:13:32.180Z Has data issue: false hasContentIssue false

CITALOPRAM

Published online by Cambridge University Press:  03 May 2024

Stephen M. Stahl
Edited in association with
Jeffrey R. Strawn
Stephen M. Stahl
Affiliation:
University of California, San Diego
Jeffrey R. Strawn
Affiliation:
University of Cincinnati, Ohio
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Prescriber's Guide – Children and Adolescents
Stahl's Essential Psychopharmacology
 , pp. 119 - 130
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

Alaghband-Rad, J, Hakimshooshtary, M. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). Eur Child Adolesc Psychiatry 2009;18(3):131–5.CrossRefGoogle ScholarPubMed
Aldrich, SL, Poweleit, EA, Prows, CA et al. Influence of CYP2C19 metabolizer status on escitalopram/citalopram tolerability and response in youth with anxiety and depressive disorders. Front Pharmacol 2019;10:99.CrossRefGoogle ScholarPubMed
Bousman, CA, Stevenson, JM, Ramsey, LB et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther 2023;114(1):51–68.CrossRefGoogle ScholarPubMed
Bridge, JA, Iyengar, S, Salary, CB et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007;297(15):1683–96.CrossRefGoogle ScholarPubMed
Croarkin, PE, Elmaadawi, AZ, Aaronson, ST et al. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial. Neuropsychopharmacology 2021;46(2):462–9.CrossRefGoogle ScholarPubMed
Czaja, AS, Valuck, RJ, Anderson, HD. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events. Pharmacoepidemiol Drug Saf 2013;22(6):607–14.CrossRefGoogle ScholarPubMed
Hathaway, EE, Walkup, JT, Strawn, JR. Antidepressant treatment duration in pediatric depressive and anxiety disorders: how long is long enough? Curr Probl Pediatr Adolesc Health Care 2018;48(2):31–9.Google Scholar
King, BH, Hollander, E, Sikich, L et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry 2009;66(6):583–90.CrossRefGoogle ScholarPubMed
Kreilgaard, M, Smith, DG, Brennum, LT, Sánchez, C. Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice. Br J Pharmacol 2008;155(2):276–84.CrossRefGoogle ScholarPubMed
Lu L, , Mills, JA, Li, Hailong et al. Acute neurofunctional effects of escitalopram in pediatric anxiety: a double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2021;60(10):1309-18.Google ScholarPubMed
Matthäus, F, Haddjeri, N, Sánchez, C et al. The allosteric citalopram binding site differentially interferes with neuronal firing rate and SERT trafficking in serotonergic neurons. Eur Neuropsychopharmacol 2016;26(11):1806–17.CrossRefGoogle ScholarPubMed
Sangkuhl, K, Klein, TE, Altman, RB. PharmGKB summary: citalopram pharmacokinetics pathway. Pharmacogenet Genomics 2011;21(11):769–72.CrossRefGoogle ScholarPubMed
Simonoff, E, Mowlem, F, Pearson, et al. Citalopram did not significantly improve anxiety in children with autism spectrum disorder undergoing treatment for core symptoms: secondary analysis of a trial to reduce repetitive behaviors. J Child Adolesc Psychopharmacol 2022;32(4):233–41.CrossRefGoogle Scholar
Strawn, JR, Mills, JA, Sauley, BA, Welge, JA. The impact of antidepressant dose and class on treatment response in pediatric anxiety disorders: a meta-analysis. J Am Acad Child Adolesc Psychiatry 2018;57(4):235–44.e2.CrossRefGoogle ScholarPubMed
Strawn, JR, Mills, JA, Poweleit, EA, Ramsey, LB, Croarkin, PE. Adverse effects of antidepressant medications and their management in children and adolescents. Pharmacotherapy 2023;43(7):675–90.CrossRefGoogle ScholarPubMed
Vaughn, SE, Strawn, JR, Poweleit, EA, Sarangdhar, M, Ramsey, LB. The impact of marijuana on antidepressant treatment in adolescents: clinical and pharmacologic considerations. J Pers Med 2021;11(7):615.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • CITALOPRAM
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781009267526.013
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • CITALOPRAM
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781009267526.013
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • CITALOPRAM
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781009267526.013
Available formats
×